- Category
- Micro (2021-22)
- Udyam number
- UDYAM-BR-26-0009622

Astermed Pharmaceuticals Private Limited
About Astermed Pharmaceuticals Private Limited
Data last updated:
Astermed Pharmaceuticals Private Limited is a private limited company based in Patna, Bihar, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 04 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Patna, under CIN U24290BR2021PTC049905.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Sangita Devi and Dipak Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Arjun Kumar Singh 797 Mahavir Colony Jaganpura Road R. K. Nagar East, Patna, Bihar, India – 800027.
As per the financials filed for FY 2025, the company reported a revenue of ₹16.97 Lakh, a growth of 28% compared to the previous year. For the same year it recorded a net profit of ₹2,904 (net margin 0.2%) and EBITDA of ₹22,464 (EBITDA margin 1.3%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years.
Astermed Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-BR-26-0009622).
Company details
Recognitions & Rankings of Astermed Pharmaceuticals
Contact details
Astermed Pharmaceuticals Private Limited's registered office is in Patna, Bihar.
- Registered AddressArjun Kumar Singh 797 Mahavir Colony Jaganpura Road R. K. Nagar East, Patna, Bihar, India – 800027
- IndustryChemicals, Manufacturing, Other Chemical Product
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Astermed Pharmaceuticals is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Astermed Pharmaceuticals Private Limited, buy the company report.
Financials of Astermed Pharmaceuticals Private Limited
FY 2025 filings availableAstermed Pharmaceuticals Private Limited reported revenue of ₹16.97 Lakh (up 28% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 19% over three years, including 28% growth in the latest year. EBITDA rose 45% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22,464 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹2,904 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.3% | ||||
| Net Profit Margin | 0.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Astermed Pharmaceuticals Private Limited, buy the company report.
Board of directors of Astermed Pharmaceuticals Private Limited
Astermed Pharmaceuticals has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sangita Devi | Director | 20 Oct 2022 | 4 Years 0 Months | Current |
| Dipak Kumar | Director | 20 Oct 2022 | 4 Years 0 Months | Current |
| Manav Kumar | Director | 04 Jan 2021 | 5 Years 10 Months | Current |
Legal cases
No court or tribunal cases involving Astermed Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Astermed Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Astermed Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Astermed Pharmaceuticals Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Suraj Kumar ceased to be Director on 10 Jan 2023.
Frequently asked questions
Astermed Pharmaceuticals is an active private limited company based in Patna, Bihar, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 04 January 2021 (5+ years old) and is registered under CIN U24290BR2021PTC049905.
Astermed Pharmaceuticals has 3 current directors:
- Sangita Devi - Director
- Dipak Kumar - Director
- Manav Kumar - Director
The latest financial statements of Astermed Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Astermed Pharmaceuticals is U24290BR2021PTC049905. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Astermed Pharmaceuticals was incorporated on 04 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Patna.
Suraj Kumar ceased to be Director on 10 Jan 2023. Dipak Kumar was appointed as Director on 20 Oct 2022. Sangita Devi was appointed as Director on 20 Oct 2022. Astermed Pharmaceuticals has 4 board changes on record in total.
Yes, Astermed Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-BR-26-0009622).
The registered office of Astermed Pharmaceuticals is at Arjun Kumar Singh 797 Mahavir Colony Jaganpura Road R. K. Nagar East, Patna, Bihar, India – 800027.
Astermed Pharmaceuticals operates in the chemicals industry, in the manufacturing segment.
Astermed Pharmaceuticals can be reached at its registered office: Arjun Kumar Singh 797 Mahavir Colony Jaganpura Road R. K. Nagar East, Patna, Bihar, India – 800027.

